GGrantIndex
← Search

PRECISION ANTIBODY-BASED SYNERGISTIC DRUG COMBINATIONS FOR REFRACTORY TRIPLE-NEGATIVE BREAST CANCER

$781,530FY2021Department of the ArmyDOD

The General Hospital Corporation

Investigators

View source on USAspending →
PRECISION ANTIBODY-BASED SYNERGISTIC DRUG COMBINATIONS FOR REFRACTORY TRIPLE-NEGATIVE BREAST CANCER · GrantIndex